![](/img/cover-not-exists.png)
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
Bria, E., Milella, M., Cuppone, F., Novello, S., Ceribelli, A., Vaccaro, V., Sperduti, I., Gelibter, A., Scagliotti, G. V., Cognetti, F., Giannarelli, D.Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq742
Date:
October, 2011
File:
PDF, 404 KB
english, 2011